EpiBiologics | $107,000,000 | (Jan 9, 2026)
Corsera Health | $80,000,000 | (Jan 9, 2026)
Oasys | $4,600,000 | (Jan 9, 2026)
Confirm
United States
- San Francisco, CA
- 31/08/2023
- Series A
- $6,200,000
Confirm is a venture-backed, all-in-one people platform fixing what’s broken with performance reviews. Grounded in the science of Organizational Network Analysis (ONA), Confirm empowers leaders with a true view of each employee’s influence, impact, and actual contribution. All with less time and effort. Unveil unique data to promote, PIP, and retain talent with precision and confidence.
- Industry Software Development
- Website https://www.confirm.com/
- LinkedIn https://www.linkedin.com/company/confirmhr/about/
Related People
Josh MerrillFounder
United States -
San Francisco Bay Area
Confirm is an all-in-one people platform fixing what’s broken with performance reviews. Grounded in the science of Organizational Network Analysis (ONA), Confirm empowers leaders with a true view of each employee’s influence, impact, and actual contribution. All with less time and effort. Unveil unique data to promote, PIP, and retain talent with precision and confidence.
Vizgen | $48,000,000 | (Jan 9, 2026)
Poplar Therapeutics | $50,000,000 | (Jan 9, 2026)
Carna Health | $8,000,000 | (Jan 9, 2026)
Alveus Therapeutics Inc | $160,000,000 | (Jan 9, 2026)
AgileRL | $7,500,000 | (Jan 9, 2026)
Soley Therapeutics | $200,000,000 | (Jan 9, 2026)
SpangleAI | $15,000,000 | (Jan 9, 2026)
Presto Phoenix, Inc. | $10,000,000 | (Jan 9, 2026)
CHAMP | $55,000,000 | (Jan 7, 2026)